CIK 0001768446 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Climb Bio, Inc.
Sign in to watch- Ticker
- CLYM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832273741
- Phone
- 1-866-857-2596
- Business address
- 20 WILLIAM STREET, SUITE G50, WELLESLEY HILLS, MA
- Former names
- Eliem Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,366,820
- in 1 filing, $1.4M under 10b5-1 plans
Net −$1,366,820. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-05 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +7,111 | $3.50 | $25K | 3,403,429 |
| 2025-12-12 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +101,462 | $2.86 | $290K | 3,396,318 |
| 2025-12-11 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +213,099 | $2.18 | $465K | 3,294,856 |
| 2024-06-27 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +11,949,171 | $3.84 | $45.9M | 23,521,757 |
| 2024-06-27 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +1,059,375 | $3.84 | $4.1M | 2,866,375 |
| 2021-08-12 | AI ETI LLC 10% owner | Purchase | +800,000 | $12.50 | $10.0M | 5,009,400 |
| 2021-08-12 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +3,004,782 | $12.50 | $37.6M | 10,599,586 |
| 2021-08-12 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +195,218 | $12.50 | $2.4M | 483,679 |
Page 1 of 1 · 8 trades